CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
EMBJ
Embraer S.A.
There isn't enough reported data to score EMBJ yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
EMBJ Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
EMBJ's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over EMBJ in the historical PE scenario, which offers more potential upside but is not a forecast.
EMBJ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 29x | $14.00 | -82% |
| Fair | 33x | $16.04 | -80% |
| Expensive | 41x | $19.86 | -75% |
| Current | 166x | $79.48 | — |
Historical ranges are pointers, not guarantees.
EMBJ's PE is 166x, but its earnings don't support one, so it isn't a reliable read right now.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
EMBJ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Growth | |
| -- | |
| Limited | |
| -- |
Analysts expect EMBJ's revenue to grow, but its earnings to decline.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
EMBJ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.48 | 0% |
| Q4 2024 | $0.48 | +118% |
| Q4 2023 | $0.22 | +$0.47 |
| Q4 2022 | -$0.25 | -$0.19 |
| Q4 2021 | -$0.06 | +$0.93 |
| Q4 2020 | -$0.99 | -$0.55 |
| Q4 2019 | -$0.44 | -$0.20 |
| Q4 2018 | -$0.24 | -171% |
EMBJ has the edge over CAT in the latest year-over-year earnings comparison.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
EMBJ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $7.6B | +18% |
| Q4 2024 | $6.4B | +21% |
| Q4 2023 | $5.3B | +16% |
| Q4 2022 | $4.5B | +8.2% |
| Q4 2021 | $4.2B | +11% |
| Q4 2020 | $3.8B | +44% |
| Q4 2019 | $2.6B | -48% |
| Q4 2018 | $5.1B | -13% |
EMBJ has the edge over CAT in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 8% | +3.2 points |
| Q4 2024 | 10% | +19 points |
| Q4 2023 | 6% | +12 points |
| Q4 2022 | -2.4% | -3.1 points |
| Q4 2021 | 4.8% | -0.8 points |
| Q4 2020 | -8.6% | -20 points |
| Q4 2019 | -6.2% | -4.3 points |
| Q4 2018 | 0.7% | N/A |
EMBJ's operating margin was 8% last quarter, up 3.2 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
EMBJ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $682.8M | +1.8% |
| Q4 2024 | $670.8M | +77% |
| Q4 2023 | $378.3M | -38% |
| Q4 2022 | $615.1M | +49% |
| Q4 2021 | $413.6M | +$1.8B |
| Q4 2020 | -$1.4B | -329% |
| Q4 2019 | $609.3M | -36% |
| Q4 2018 | $953.3M | +83% |
EMBJ generated $2.3B in free cash flow over the past year, about four times what it generated the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over EMBJ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
EMBJ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -2.2M shares |
| 1 year | -0.5% | -3.4M shares |
EMBJ has 732M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2021 | $2.5M |
| Q4 2017 | $15M |
| Q4 2016 | — |
| Q3 2016 | $742,113 |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
EMBJ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2018 | -3.1x | Net Cash |
| Q4 2017 | -1.4x | Net Cash |
EMBJ has more cash than debt.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
EMBJ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 62.6 | Neutral |
EMBJ's weekly RSI is 64 (neutral) and its Stochastic is 63 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over EMBJ on valuation relative to its sector.
EMBJ PE vs Industrials Sector
| Metric | EMBJ | Sector median | Relative |
|---|---|---|---|
| PE | 166x | 24x | 589% above |
| PE % | 100 | 58 | 42 pts above |
EMBJ is trading at 166x earnings, a 589% premium to the Industrials sector's median of 24x, though its earnings don't support one.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
EMBJ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $74.4 | 6.8% above |
| 20 week MA | $72.2 | 10% above |
| 50 week MA | $67.4 | 18% above |
| 100 week MA | $59.2 | 34% above |
| 200 week MA | $40.5 | 96% above |
EMBJ has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
EMBJ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.4 | $6.52 | -66% |
| 2021 | $6.52 | $17.2 | +163% |
| 2022 | $17.2 | $11.0 | -36% |
| 2023 | $11.0 | $18.5 | +68% |
| 2024 | $18.5 | $36.5 | +98% |
| 2025 | $36.5 | $64.4 | +77% |
| 2026 YTD | $64.4 | $79.5 | +23% |
EMBJ has the edge over CAT on returns for 2026, with the stronger performance.